Objectives
After participating in this educational activity, attendees should be able to:
1|Apply cardiovascular risk stratification tools to assess patients’ cardiovascular risk and guide appropriate preventive and treatment strategies.
2|Improve surveillance and treatment of patients with IPF, sarcoidosis, and CTD-ILD
3|Improve screening methods for pulmonary hypertension and apply updated evidence to caring for patients with pulmonary embolism
Presenter(s):
Victor Pinto-Plata, MD
Division Chair
Pulmonary and Critical Care Medicine
Lahey Hospital and Medical Center
Associate Professor of Medicine
UMass Chan Medical School
Mohammad Abu-Hishmeh, MD, MBA, FCCP
Program Director, Critical Care Fellowship Program
Director, Interstitial Lung Disease Program
Assistant Professor of Medicine, UMass Chan Medical School-Baystate
Division of Pulmonary and Critical Care Medicine
Baystate Medical Center
Neil Devoe, DO
Assistant Medical Director, Pulmonary Hypertension
Division of Pulmonary and Critical Care Medicine
Baystate Medical Center.
| Name | Role | Financial Relationship Disclosures | Discussion of Unlabeled/Unapproved Uses of Drugs/Devices in Presentation? |
|---|---|---|---|
| Victor Pinto-Plata, MD | Speaker | No relevant relationships with ineligible companies to disclose | No |
| Neil Devoe, DO | Speaker | No relevant relationships with ineligible companies to disclose | No |
| Mohammad Abu-Hishmeh, MD, MBA, FCCP | Speaker | Boehringer Ingelheim - Speaker and Consultant | No |
- 1.00 AAPA Category 1 CME creditBaystate Health has been authorized by the American Academy of PAs (AAPA) to award AAPA Category 1 CME credit for activities planned in accordance with AAPA CME Criteria. This activity is designated for 1.00 AAPA Category 1 CME credits. PA’s should only claim credit commensurate with the extent of their participation.
- 1.00 AMA PRA Category 1 Credit™
- 1.00 BCIPE Instructional Hours
Facebook
X
LinkedIn
Forward